Price $332.10 |
Market Cap
47.96B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
118.2
|
P/B
19.71
|
P/S
30.86
|
Dividend %
-
|
|
P/CF
110.8
|
P/FCF
-
|
Op. Cash Flow
747.5K
|
FCF
-
|
|
Op. Margin
26.80%
|
Net Margin
26.20%
|
ROE
18.60%
|
ROI
16.00%
|
|
ROA
14.40%
|
EPS Growth
27.60%
|
Current Ratio
3.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $29.59 | - | - | 10.52B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $68.15 | - | 2.90% | 148.62B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.13 | - | - | 60.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
